Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1986 Feb;49(2):211–215. doi: 10.1136/jnnp.49.2.211

Trace elements in the spinal cord and other tissues in motor neuron disease.

J D Mitchell, B W East, I A Harris, R J Prescott, B Pentland
PMCID: PMC1028692  PMID: 3950642

Abstract

Trace elements were estimated in the spinal cord, liver and bone of five patients dying of motor neuron disease and five control subjects dying of non-neurological disease. The content of selenium in cord and liver and the cord manganese level were significantly increased in the motor neuron disease patients. These findings are discussed in terms of the possible aetiology of motor neuron disease.

Full text

PDF
211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams C. R., Ziegler D. K., Lin J. T. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA. 1983 Aug 5;250(5):642–643. [PubMed] [Google Scholar]
  2. Barber T. E. Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J Occup Med. 1978 Oct;20(10):667–669. [PubMed] [Google Scholar]
  3. Bradley W. G., Krasin F. A new hypothesis of the etiology of amyotrophic lateral sclerosis. The DNA hypothesis. Arch Neurol. 1982 Nov;39(11):677–680. doi: 10.1001/archneur.1982.00510230003001. [DOI] [PubMed] [Google Scholar]
  4. Campbell A. M., Williams E. R., Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877–885. doi: 10.1136/jnnp.33.6.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davidson T. J., Hartmann H. A. Base composition of RNA obtained from motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1981 Mar;40(2):193–198. doi: 10.1097/00005072-198103000-00010. [DOI] [PubMed] [Google Scholar]
  6. Davidson T. J., Hartmann H. A. RNA content and volume of motor neurons in amyotrophic lateral sclerosis. II. The lumbar intumescence and nucleus dorsalis. J Neuropathol Exp Neurol. 1981 Mar;40(2):187–192. doi: 10.1097/00005072-198103000-00009. [DOI] [PubMed] [Google Scholar]
  7. Kilness A. W., Hichberg F. H. Amyotrophic lateral sclerosis in a high selenium environment. JAMA. 1977 Jun 27;237(26):2843–2844. [PubMed] [Google Scholar]
  8. Kurlander H. M., Patten B. M. Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol. 1979 Jul;6(1):21–24. doi: 10.1002/ana.410060105. [DOI] [PubMed] [Google Scholar]
  9. Livesley B., Sissons C. E. Chronic lead intoxication mimicking motor neurone disease. Br Med J. 1968 Nov 9;4(5627):387–388. doi: 10.1136/bmj.4.5627.387-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mandybur T. I., Cooper G. P. Increased spinal cord lead content in amyotrophic lateral sclerosis--possibly a secondary phenomenon. Med Hypotheses. 1979 Dec;5(12):1313–1315. doi: 10.1016/0306-9877(79)90099-9. [DOI] [PubMed] [Google Scholar]
  11. Mitchell J. D., Harris I. A., East B. W., Pentland B. Trace elements in cerebrospinal fluid in motor neurone disease. Br Med J (Clin Res Ed) 1984 Jun 16;288(6433):1791–1792. doi: 10.1136/bmj.288.6433.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Miyata S., Nakamura S., Nagata H., Kameyama M. Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis. J Neurol Sci. 1983 Oct;61(2):283–293. doi: 10.1016/0022-510x(83)90012-6. [DOI] [PubMed] [Google Scholar]
  13. Norris F. H., Jr, U K. S. Amyotrophic lateral sclerosis and low urinary selenium levels. JAMA. 1978 Jan 30;239(5):404–404. [PubMed] [Google Scholar]
  14. Petkau A., Sawatzky A., Hillier C. R., Hoogstraten J. Lead content of neuromuscular tissue in amyotrophic lateral sclerosis: case report and other considerations. Br J Ind Med. 1974 Oct;31(4):275–287. doi: 10.1136/oem.31.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SIMPSON J. A., SEATON D. A., ADAMS J. F. RESPONSE TO TREATMENT WITH CHELATING AGENTS OF ANAEMIA, CHRONIC ENCEPHALOPATHY, AND MYELOPATHY DUE TO LEAD POISONING. J Neurol Neurosurg Psychiatry. 1964 Dec;27:536–541. doi: 10.1136/jnnp.27.6.536. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES